Relative Strength Chart Akeso, Inc.

Stocks

Delayed Hong Kong S.E. Other stock markets 10:34:07 18/06/2026 am IST			5-day change	1st Jan Change
87.35 ^HKD	+4.11%		-0.46%	-22.65%

17/06	Akeso Presents Phase Ii Results for Ligufalimab-Based Combination in Frontline Acute Myeloid Leukemia	CI
15/06	Akeso Enrolls First Patient in Phase Ib/Ii Clinical Study of Next-Generation Her3 Antibody-Drug Conjugate Ak138d1 for Advanced Breast Cancer	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	AKESO, INC.	Bio Therapeutic Drugs	+4.11%	-0.46%	-22.65%	-7.76%	+41.42%	986.36Cr